Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?

Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):390-393. doi: 10.1016/j.ijrobp.2020.06.049.

Authors

Diane C Ling¹, John A Vargo¹, Sushil Beriwal²

Affiliations

¹ Department of Radiation Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital, Pittsburgh, Pennslyvania.
² Department of Radiation Oncology, UPMC Hillman Cancer Center, Magee Women's Hospital, Pittsburgh, Pennslyvania. Electronic address: beriwals@upmc.edu.

No abstract available

Publication types

Editorial

MeSH terms

Breast Neoplasms / radiotherapy*
COVID-19 / epidemiology*
Chemoradiotherapy / methods
Chemoradiotherapy / standards
Evidence-Based Medicine
Female
Humans
Male
Prostatic Neoplasms / radiotherapy*
Radiation Dose Hypofractionation / standards*
Radiosurgery
Randomized Controlled Trials as Topic
Rectal Neoplasms / radiotherapy*